Company Description

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.

The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.

It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.

The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Inspire Medical Systems, Inc.

Country	United States
Founded	2007
IPO Date	May 3, 2018
Industry	Medical Devices
Sector	Healthcare
Employees	1,011
CEO	Timothy Herbert

Contact Details

Address: 5500 Wayzata Blvd., Suite 1600 Golden Valley, Minnesota 55416 United States
Phone	844 672 4357
Website	inspiresleep.com

Stock Details

Ticker Symbol	INSP
Exchange	NYSE
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001609550
CUSIP Number	457730109
ISIN Number	US4577301090
Employer ID	26-1377674
SIC Code	3841

Key Executives

Name	Position
Timothy Herbert	Chief Executive Officer
Richard Buchholz	Chief Financial Officer
Ezgi Yagci	Head of Investor Relations

Latest SEC Filings

Date	Type	Title
Nov 12, 2024	SC 13G/A	[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 12, 2024	8-K	Current Report
Nov 4, 2024	10-Q	Quarterly Report
Nov 4, 2024	8-K	Current Report
Nov 1, 2024	144	Filing
Oct 7, 2024	SC 13G/A	[Amend] Statement of acquisition of beneficial ownership by individuals
Oct 4, 2024	SC 13G/A	[Amend] Statement of acquisition of beneficial ownership by individuals
Sep 11, 2024	144	Filing
Sep 9, 2024	144	Filing
Sep 9, 2024	144	Filing

View All SEC Filings